Table 1.
Clinical characteristics of the participants.
| Control (n = 5) | Obesity (n = 5) | T2DM (n = 5) | T1DM (n = 5) | P | |
|---|---|---|---|---|---|
| Sex [fem], n (%) | 2 (40%) | 2 (40%) | 3 (60%) | 2 (40%) | 0.895† |
| Age [months] | 166 (133, 183) | 159 (124, 188) | 174 (129, 202) | 158 (133, 210) | 0.915‡ |
| ZS IMC (DE) | 0.21 (−0.05, 0.53) | 2.86 (2.63, 3.96) | 0.71 (−0.34, 2.55) | −0.46 (−1.07, 1.17) | <0.001‡ |
| Evolution [months] | — | — | 28 (12, 56) | 30 (0, 60) | 0.882‡ |
| Glucose [mg/dL] | 91 (81, 92) | 95 (90, 98) | 103 (96, 308) | 300 (185, 518) | 0.013‡ |
| HbA1c [%] | 5.6 (5.2, 6.0) | 4.9 (4.6, 5.1) | 7.7 (5.3, 12.8) | 12.5 (10.8, 14.0) | 0.002‡ |
| Toral cholesterol [mg/dL] | 92 (74, 140) | 151 (105, 184) | 169 (100, 312) | 178 (123, 212) | 0.044‡ |
| HDL-C [mg/dL] | 43 (33, 57) | 33 (31, 40) | 50 (32, 68) | 41 (38, 48) | 0.072‡ |
| Triglycerides (mg/dL) | 65 (52, 115) | 195 (120, 259) | 173 (50, 537) | 82 (48, 400) | 0.066‡ |
| Uric acid (mg/dL) | 6.4 (3.9, 6.7) | 5.5 (3.5, 6.7) | 4.3 (3.6, 4.9) | 3.6 (3.1, 9.3) | 0.463‡ |
| Insulin Tx. [Sí], n (%) | — | — | 0 (0%) | 6 (100%) | 0.002† |
| Insulin dosage | — | — | — | 0.81 (0.54, 1.14) | — |
T2DM: type 2 diabetes mellitus group, T1DM: type 1 diabetes mellitus group, n: sample size. P values were calculated by chi-square teste, if the dependent variable was categorical, and by Welch’s test, if the dependent variable was continuous. The pairs do not share the same letter were different al the level of p < 0.05.